sec filing

NASDAQ · AVXL
Anavex Life Sciences Corp.
Healthcare · Biotechnology
$1.82
Down-$0.07 (-3.70%)
Updated Oct 3, 2026, 4:38 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 367.21M
- P/E ratio
- -7.28
- Dividend yield
- 0.00%
- 52-week range
- $1.88 – $10.38
- Volume
- 1.99M
- Avg. volume
- 2.3M
Price performance · AVXL
AVXL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
AVXL closed at $1.82 after 20 trading sessions, down 36.36% for the selected period.
- Last close
- $1.82
- Period change
- -36.36%
- Period low
- $1.82
- Period high
- $2.86
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $1.88 | $1.88 | $1.72 | $1.82 | 1.99M |
| Oct 1, 2026 | $2.00 | $2.01 | $1.88 | $1.89 | 2.34M |
| Sep 30, 2026 | $2.38 | $2.38 | $1.89 | $2.02 | 2.97M |
| Sep 29, 2026 | $2.35 | $2.415 | $2.31 | $2.36 | 1.76M |
| Sep 28, 2026 | $2.42 | $2.4308 | $2.35 | $2.35 | 522.54K |
| Sep 25, 2026 | $2.35 | $2.43 | $2.32 | $2.38 | 744.39K |
| Sep 24, 2026 | $2.33 | $2.37 | $2.27 | $2.34 | 937.05K |
| Sep 23, 2026 | $2.47 | $2.49 | $2.305 | $2.35 | 779.17K |
| Sep 22, 2026 | $2.41 | $2.485 | $2.39 | $2.47 | 639.99K |
| Sep 21, 2026 | $2.42 | $2.42 | $2.35 | $2.40 | 574.48K |
| Sep 18, 2026 | $2.42 | $2.45 | $2.38 | $2.42 | 920.59K |
| Sep 17, 2026 | $2.41 | $2.48 | $2.405 | $2.41 | 364.75K |
| Sep 16, 2026 | $2.44 | $2.4699 | $2.31 | $2.36 | 906.1K |
| Sep 15, 2026 | $2.59 | $2.59 | $2.43 | $2.44 | 946.24K |
| Sep 14, 2026 | $2.61 | $2.64 | $2.55 | $2.60 | 658.13K |
| Sep 11, 2026 | $2.71 | $2.7373 | $2.61 | $2.62 | 624.49K |
| Sep 10, 2026 | $2.71 | $2.735 | $2.615 | $2.66 | 433.77K |
| Sep 9, 2026 | $2.84 | $2.895 | $2.74 | $2.75 | 438.58K |
| Sep 8, 2026 | $2.81 | $2.88 | $2.77 | $2.85 | 559.14K |
| Sep 4, 2026 | $2.82 | $2.905 | $2.81 | $2.86 | 307.15K |
Latest AVXL news
The latest Smart Investors Daily articles mentioning AVXL.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

